Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Semergen|August 21, 2016
[Opinion from physicians on the need for dyslipidemia screening in cardiovascular risk. Similarities and differences between primary care and other specialties. The DIANA study]Adalberto Serrano, Vicente Pascual, Journal of Medical Economics|September 8, 2012
Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in SpainVivencio Barrios, José M Lobos, Adalberto Serrano, et al.Journal of Clinical Medicine|August 29, 2024
Hyperuricaemia Prevalence Rates According to Their Physiochemical and Epidemiological Diagnostic Criteria and Their Associations with Cardio-Renal-Metabolic Factors: SIMETAP-HU StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Ezequiel Arranz-Martínez, et al.Medicina (Kaunas, Lithuania)|August 29, 2024
Atrial Fibrillation Prevalence Rates and Its Association with Cardiovascular-Kidney-Metabolic Factors: SIMETAP-AF StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, et al.Nutrients|November 27, 2024
Prevalence Rates of Abdominal Obesity, High Waist-to-Height Ratio and Excess Adiposity, and Their Associated Cardio-Kidney-Metabolic Factors: SIMETAP-AO StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, et al.Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|November 20, 2016
[Chronic kidney disease and dyslipidaemia]Vicente Pascual, Adalberto Serrano, Juan Pedro-Botet, et al.Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 27, 2017
The application of atherogenic dyslipidaemia consensus recommendations in the primary care setting. DAT-AP studyAngel Díaz Rodríguez, Adalberto Serrano Cumplido, Jesús Millán Nuñez-Cortés, et al.Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|March 8, 2016
[Delphi consensus on management of dyslipidaemia in patients with impaired glucose metabolism: Diana study]Juan Pedro-Botet, Vivencio Barrios, Vicente Pascual, et al.Journal of Clinical Medicine|June 13, 2025
From the Cardiovascular-Kidney-Metabolic Disorders to the Atherosclerotic Cardiovascular Diseases: Their Prevalence Rates and Independent Associations in the SIMETAP StudyAntonio Ruiz-García, Vicente Pallarés-Carratalá, Adalberto Serrano-Cumplido, et al.Journal of Clinical Medicine|August 12, 2023
Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF StudyAntonio Ruiz-García, Adalberto Serrano-Cumplido, Carlos Escobar-Cervantes, et al.Pageof 2